Substance / Medication

Ertapenem

Overview

Active Ingredient
ertapenem
RxNorm CUI
325642

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

12 trials linked to this intervention

12
Total Trials
1
Recruiting
4
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Effectiveness of ertapenem for treatment of infections in children: An evidence mapping and meta-analysis.
Zhao Ruiqiu, Long Xiaoru, Wang Jiangxia et al. · Front Pediatr · 2022
PMID: 36324821Meta-AnalysisFull text (PMC)
Ertapenem versus ceftriaxone for the treatment of complicated infections: a meta-analysis of randomized controlled trials.
Bai Nan, Sun Chunguang, Wang Jin et al. · Chin Med J (Engl) · 2014
PMID: 24622445Meta-Analysis
Ertapenem use and antimicrobial resistance to group 2 carbapenems in Gram-negative infections: a systematic review.
Falagas Matthew E, Tansarli Giannoula S, Kapaskelis Anastasios et al. · Expert Rev Anti Infect Ther · 2013
PMID: 23428103Meta-Analysis
Meta-analysis: ertapenem for complicated intra-abdominal infections.
Falagas M E, Peppas G, Makris G C et al. · Aliment Pharmacol Ther · 2008
PMID: 18266994Meta-Analysis
A phase 3 randomized trial of sulopenem vs. ertapenem in patients with complicated intra-abdominal infections.
Dunne Michael W, Aronin Steven I, Das Anita F et al. · Clin Microbiol Infect · 2025
PMID: 39491784RCT
Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trial.
de Vries Henry J C, de Laat Myrthe, Jongen Vita W et al. · Lancet Infect Dis · 2022
PMID: 35065063RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Ertapenem (substance)
SNOMED CT
396346003
UMLS CUI
C1120106
RxNorm CUI
325642

Clinical Data

This intervention maps to 20 entities in the Healos knowledge graph.

15
Conditions
2
Biomarkers
2
Specialists
0
Symptoms
12
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.